As technology advances, the FDA must keep pace with the increasing complexity of rapidly developing technology and continue to modernize and evaluate our programs and processes, ensuring they continue to be efficient, consistent and scientifically rigorous.
“To promote these goals, we’re launching a new optional 510(k) submission template that allows pilot participants to submit applications to the FDA using a more dynamic electronic format capable of organizing the complex information necessary for a robust scientific review. Without changing our statutory or data requirements, this highly-interactive submission template is intended to allow manufacturers to provide information to the FDA that’s complementary to ..."
No hay comentarios:
Publicar un comentario